Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation*

Protease-activated receptor 1 (PAR1), a G protein-coupled receptor (GPCR) for thrombin, is the prototypic member of a family of protease-activated receptors. PAR1 is irreversibly proteolytically activated; thus, the magnitude and duration of thrombin cellular responses are determined primarily by mechanisms responsible for termination of receptor signaling. Both phosphorylation and β-arrestins contribute to rapid desensitization of PAR1 signaling. However, the relative contribution of each of these pathways to the termination of PAR1 signaling is not known. Co-expression of PAR1 with β-arrestin 1 (βarr1) in COS-7 cells resulted in a marked inhibition of PAR1 signaling, whereas β-arrestin 2 (βarr2) was essentially inactive. Strikingly, signaling by a PAR1 cytoplasmic tail mutant defective in agonist-induced phosphorylation was also attenuated more effectively by βarr1 compared with βarr2. In contrast, both β-arrestin isoforms were equally effective at desensitizing the substance P receptor, a classic reversibly activated GPCR. PAR1 coimmunoprecipitated βarr1 in an agonist-dependent manner, whereas βarr2 association was virtually undetectable. Remarkably, βarr1 also interacted with phosphorylation defective PAR1 mutant, whereas βarr2 did not. Moreover, constitutively active β-arrestin mutants, βarr1 R169E and βarr2 R170E, that bind to activated receptor independent of phosphorylation failed to enhance either wild type or mutant PAR1 desensitization compared with normal versions of these proteins. In contrast, β-arrestin mutants displayed enhanced activity at desensitizing the serotonin 5-hydroxytryptamine2A receptor. Taken together, these results suggest that, in addition to PAR1 cytoplasmic tail phosphorylation itself, β-arrestin binding independent of phosphorylation promotes desensitization of PAR1 signaling. These findings reveal a new level of complexity in the regulation of protease-activated GPCR signaling.

[1]  Bryan L Roth,et al.  The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization. , 2003, Molecular pharmacology.

[2]  H. Hamm,et al.  Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2* , 2002, The Journal of Biological Chemistry.

[3]  C. Chavkin,et al.  Conservation of the Phosphate-sensitive Elements in the Arrestin Family of Proteins* , 2002, The Journal of Biological Chemistry.

[4]  N. Bunnett,et al.  Heterologous regulation of trafficking and signaling of G protein-coupled receptors: β-Arrestin-dependent interactions between neurokinin receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Kohout,et al.  β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation* , 2002, The Journal of Biological Chemistry.

[6]  T. Kohout,et al.  Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin , 2001, Science.

[7]  L. Brass,et al.  Protease activated receptors: theme and variations , 2001, Oncogene.

[8]  T. Kohout,et al.  beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[10]  A. Malik,et al.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Bunnett,et al.  Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor. , 1999, The Journal of biological chemistry.

[12]  M. Caron,et al.  Cellular Trafficking of G Protein-coupled Receptor/β-Arrestin Endocytic Complexes* , 1999, The Journal of Biological Chemistry.

[13]  M. Caron,et al.  Real-time Visualization of the Cellular Redistribution of G Protein-coupled Receptor Kinase 2 and β-Arrestin 2 during Homologous Desensitization of the Substance P Receptor* , 1999, The Journal of Biological Chemistry.

[14]  C. Chavkin,et al.  Targeted Construction of Phosphorylation-independent β-Arrestin Mutants with Constitutive Activity in Cells* , 1999, The Journal of Biological Chemistry.

[15]  S. Coughlin,et al.  Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand. , 1999, Biochemistry.

[16]  S. Coughlin,et al.  The Cytoplasmic Tails of Protease-activated Receptor-1 and Substance P Receptor Specify Sorting to Lysosomes versusRecycling* , 1999, The Journal of Biological Chemistry.

[17]  S. Coughlin,et al.  Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Lefkowitz,et al.  Clathrin-mediated Endocytosis of the β-Adrenergic Receptor Is Regulated by Phosphorylation/Dephosphorylation of β-Arrestin1* , 1997, The Journal of Biological Chemistry.

[19]  J. Benovic,et al.  Interaction of Arrestins with Intracellular Domains of Muscarinic and α2-Adrenergic Receptors* , 1997, The Journal of Biological Chemistry.

[20]  S. Coughlin,et al.  Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking , 1996, The Journal of Biological Chemistry.

[21]  J. Benovic,et al.  β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.

[22]  M. Caron,et al.  Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization , 1996, Science.

[23]  T. Nanevicz,et al.  Thrombin Receptor Activating Mutations , 1996, The Journal of Biological Chemistry.

[24]  J. Chen,et al.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.

[25]  S. Coughlin Thrombin receptor function and cardiovascular disease. , 1994, Trends in cardiovascular medicine.

[26]  H. Hamm,et al.  Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition. , 1994, The Journal of biological chemistry.

[27]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[28]  V. Wheaton,et al.  Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. , 1992, The Journal of clinical investigation.

[29]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[30]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[31]  T. Kohout,et al.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. , 2003, Molecular pharmacology.

[32]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.